Insurance coverage is not guaranteed
Many report no serious issues
GLP-1 medications can help manage type 2 diabetes and obesity, but they may cause short-term mild-to-moderate side effects such as nausea, vomiting, diarrhoea, constipation, bloating, and decreased appetite, particularly at the beginning of treatment
We also know what our core users need in a way that no one else does
In general, the self-report data indicate that medication users often report higher doses than those recorded in their EHRs, with 88.8% of semaglutide and 84.3% of tirzepatide users self-reporting a dosage greater or equal to the EHR records
Consult PlexusDx before you skip a dose if possibleyour provider can assess whether a one-week delay fits your treatment schedule without disrupting your progress